Flexing muscles Merck and Company’s agreement to sell its consumer-product and non-prescription medicine franchises to Bayer AG for 14.2 billion US dollars (http://www.bayer.com/en/2014-05-06-acquisition-cc-business-merck.aspx) and to sell its eye care products to Japanese drug maker Santen Pharmaceutical Co. Ltd. for at least 600 million US dollars (https://www.merck.com/licensing/our-partnership/santen-partnership.html) are just the latest in a wave of mergers … Continue reading Mega mergers and acquisitions in the global pharmaceutical industry: Implications for Africa’s health industry (pt.1)
0 Comments